Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Dec;305(3):213-8.
doi: 10.1007/BF00498813.

Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover

Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover

J A García-Sevilla et al. Naunyn Schmiedebergs Arch Pharmacol. 1978 Dec.

Abstract

Intracerebroventricularly administered neurotensin and [Gln4]-neurotensin (50-200 microgram) increased the formation of Dopa in different brain regions of rats after inhibition of the aromatic L-amino acid decarboxylase. For both neuropeptides these increases were dose dependent (20-150%). In the corpus striatum [Gln4]-neurotensin was twice as active as neurotensin and it tended to be more active also in other brain regions. The brain tyrosine concentrations were also increased. [Gln4]-neurotensin (100-200 microgram) following inhibition of the aromatic L-amino acid decarboxylase, increased the accumulation of 5-hydroxytryptophan in all brain regions by 30-60%. In contrast, neurotensin was completely inactive. In both cases the brain tryptophan concentrations were increased. Both neurotensin and [Gln4]-neurotensin also accelerated the disappearance of dopamine, noradrenaline and 5-hydroxytryptamine after inhibition of monoamine synthesis. These results show an increased brain monoamine turnover induced by both neuropeptides.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Life Sci. 1976 Dec 15;19(12):1827-32 - PubMed
    1. Neuropharmacology. 1977 Sep;16(9):625-9 - PubMed
    1. Br J Pharmacol. 1973 Aug;48(4):699-714 - PubMed
    1. J Pharm Pharmacol. 1973 Jun;25(6):437-40 - PubMed
    1. J Pharm Pharmacol. 1978 Oct;30(10):613-21 - PubMed